# Pacific Biosciences of California, Inc.: Form 8-K, filed Feb 2, 2026

- Company: [Pacific Biosciences of California, Inc.](/companies/pacb.md) (CIK 1299130)
- Form: 8-K
- Filed: 2026-02-02
- Accepted by EDGAR: Feb 2, 2026, 09:25 ET
- Period: 2026-01-30
- Accession: 0001104659-26-009014
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1299130/000110465926009014/tm264755d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1299130/000110465926009014/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1299130/000110465926009014/tm264755d1_8k.htm

Filed Feb 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-009014. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.